Engineered mRNA-expressed bispecific antibody prevent intestinal cancer via lipid nanoparticle delivery

The potential of antibodies, especially for the bispecific antibodies, are limited by high cost and complex technical process of development and manufacturing. A cost-effective and rapid platform for the endogenous antibodies expression via using the in vitro transcription (IVT) technique to produce...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lipei, Wang, Weiwei, Tian, Jiale, Qi, Chunrun, Cai, Zhengxin, Yan, Wenhui, Xuan, Shihai, Shang, Anquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810065/
https://www.ncbi.nlm.nih.gov/pubmed/34895063
http://dx.doi.org/10.1080/21655979.2021.2003666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810065/
https://www.ncbi.nlm.nih.gov/pubmed/34895063
http://dx.doi.org/10.1080/21655979.2021.2003666

Ejemplares similares